The Medicines Patent Pool unveils new version of MedsPaL for streamlined access to global health intellectual property information

The Medicines Patent Pool (MPP) is pleased to announce the launch of a new version of its patents and licences database MedsPaL. MedsPalis a free resource that provides crucial information on the intellectual property status of patented essential medicines, COVID-19 vaccines, and long-acting platform technologies, with a particular focus on low- and middle-income countries (LMICs).

The latest update introduces a suite of new features designed to enhance user engagement and accessibility. Among these, the ability to save searches and set up email notifications stands out, enabling users to stay informed about the latest developments in their areas of interest. The redesigned platform now also boasts improved mobile compatibility, ensuring that users can access the information they require on-the-go. Additionally, a new licence tab has been introduced, providing detailed insights into licensing agreements. The enhanced reporting tools, including interactive maps, donut charts, and timelines, offer a dynamic way to visualise data and extract meaningful insights from the intellectual property landscape.

Created in 2016, MedsPaL serves as a comprehensive database offering insights into the intellectual property landscape of key health technologies and products, including:

• Medicines: Patented medicines on the Model lists of Essential Medicines of the World Health Organisation (WHO EML) and medicines prioritised for MPP licensing across all disease areas as well as data on patented medicines recommended by WHO for the treatment of COVID-19 in LMICs;
• Vaccines: Patent information on COVID-19 vaccines worldwide, which will evolve over time to cover other key patented vaccines:

Technologies: Long-acting technologies selected by MPP in the context of LAPaL, the Long-Acting technologies patents and licences database, another free online resource coordinated by MPP.